Cited by 64Parkinson's Disease Mechanisms and TreatmentsLysosomal Storage Disorders ResearchNuclear Receptors and Signaling

Evidence of an association between the scavenger receptor class B member 2 gene and Parkinson’s disease

Michelakakis, Helen, Xiromerisiou, Georgia, Dardiotis, Efthimios, Bozi, Maria, Vassilatis, Demetrios, Kountra, Persa‐Maria, Patramani, Gianna, Moraitou, Marina +5 more·2012·Movement Disorders

Abstract

Lysosomal protein 2 (LIMP2), the product of the scavenger receptor class B member 2 (SCARB2) gene, is a ubiquitously expressed transmembrane protein that is the mannose-6-phosphate-independent receptor for glucocerebrosidase (β-GCase); a deficiency in this protein causes Gaucher disease. Several studies have shown a link between mutations in the β-GCase gene and diseases characterized clinically by Parkinsonism and by the presence of Lewy body-related pathology. We hypothesized that genetic variants in the SCARB2 gene could be risk factors for Parkinson's disease (PD). A candidate-gene study of 347 Greek patients with sporadic PD and 329 healthy controls was conducted to investigate the association between 5 polymorphisms in the SCARB2 gene (rs6824953, rs6825004, rs4241591, rs9991821, and rs17234715) and the development of PD. The single-locus analysis for the 5 polymorphisms revealed an association only for the rs6825004 polymorphism: the generalized odds ratio (OR(G) ) was 0.68 (95% confidence interval [CI], 0.51-0.90), and the OR for the allelic test was OR = 0.71 (95% CI, 0.56-0.90). Haplotype analysis showed an association for the GCGGT haplotype (P < .01). Our study supports a genetic contribution of the SCARB2 locus to PD; future studies in larger cohorts are necessary to verify this finding.

Integrity signals

Registry

Crossref · 10.1002/mds.24886

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Since sphingolipid-containing membranes are cleared by microglia, it is possible that this region has greater need for sphingolipid clearance and is thus more susceptible to sphingolipidosis-related mutations, though this hypothesis would need much more study.

    “Since sphingolipid-containing membranes are cleared by microglia, it is possible that this region has greater need for sphingolipid clearance and is thus more susceptible to sphingolipidosis-related mutations, though this hypothesis would need much more study.110”

Cites

Flagged first, then by citations

Cited by

Authors
Michelakakis, H., Xiromerisiou, G., Dardiotis, E., Bozi, M., Vassilatis, D., Kountra, P., Patramani, G., Moraitou, M., Papadimitriou, D., Stamboulis, E., Stefanis, L., Zintzaras, E., & Hadjigeorgiou, G. M.
Affiliations
  • Institute of Child Health (GR)
  • Center for Research and Technology Thessaly (GR)
  • University of Thessaly (GR)
  • National and Kapodistrian University of Athens (GR)
  • Biomedical Research Foundation of the Academy of Athens (GR)
  • Tufts University (US)
Corresponding author
Hadjigeorgiou, Georgios M.
Venue
Movement Disorders
Publisher
Wiley
Published
2012-01-05
Volume
27
Issue
3
Pages
400-405
ISSN
  • 0885-3185 (ISSN-L)
  • 1531-8257
OpenAlex
W2020579700
Cited by
64
References
1
Citations by year
2026: 1 · 2025: 6 · 2024: 2 · 2023: 5 · 2022: 4 · 2021: 6 · 2020: 4 · 2019: 4 · 2018: 6 · 2017: 3 · 2016: 5 · 2015: 3 · 2014: 3 · 2013: 6 · 2012: 6
FWCI
3.75
Type
journal article
Language
en
Open access
closed
Locations
  • Movement Disorders (publishedVersion)
  • PubMed (publishedVersion)
  • University of Thessaly Institutional Repository (University of Thessaly) (submittedVersion)
Funders
  • Max-Planck-Gesellschaft
  • National Institutes of Health
Topics
  • Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
  • Health Sciences › Medicine › Physiology › Lysosomal Storage Disorders Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nuclear Receptors and Signaling
Keywords
Parkinson's disease, SCARB2, glucocerebrosidase, Gaucher disease, genetic susceptibility, single nucleotide polymorphisms, haplotype association, Lewy bodies, candidate gene association
MeSH terms
Female, Gene Frequency, Genotype, Greece, Humans, Male, Parkinson Disease, Retrospective Studies, Chi-Square Distribution, Odds Ratio, Case-Control Studies, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide, Receptors, Scavenger, Lysosomal Membrane Proteins, Genetic Association Studies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review